Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
How does a gastroenterologist show value?
Daniel W Hommes, Eric Esrailian
Expert Opinion on Investigational Drugs
|
December 1, 2015
Anti-TNF-α therapies for the treatment of Crohn's disease: the past, present and future
Marc Berns, Daniel W Hommes
Expert Opinion on Biological Therapy
|
February 26, 2016
Etrolizumab for ulcerative colitis: the new kid on the block?
Jitin Makker, Daniel W Hommes
Nature Reviews. Gastroenterology & Hepatology
|
February 18, 2016
Stem cells: HSCT for Crohn's disease: work in progress or a bridge too far?
Daniel W Hommes, Precious N Lacey
Gastroenterology
|
November 16, 2016
Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
Christopher J Hawkey, Daniel W Hommes
Therapeutic Advances in Gastroenterology
|
July 2, 2016
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls
Natalie E Duran, Daniel W Hommes
Current Treatment Options in Gastroenterology
|
August 12, 2006
Novel biological therapies for inflammatory bowel disease
Pieter C F Stokkers, Daniel W Hommes
Gastroenterology & Hepatology
|
August 21, 2013
Mucosal schwann cell hamartoma in ulcerative colitis: diagnosis and clinical relevance
Welmoed K van Deen, Daniel W Hommes
Nature Reviews. Gastroenterology & Hepatology
|
July 3, 2013
IBD: Antibodies to anti-TNF therapy--consequences for IBD management
Welmoed K van Deen, Daniel W Hommes
Current Gastroenterology Reports
|
March 15, 2006
Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
Luc J J Derijks, Daniel W Hommes
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
How does a gastroenterologist show value?
Daniel W Hommes, Eric Esrailian
Expert Opinion on Investigational Drugs
|
December 1, 2015
Anti-TNF-α therapies for the treatment of Crohn's disease: the past, present and future
Marc Berns, Daniel W Hommes
Expert Opinion on Biological Therapy
|
February 26, 2016
Etrolizumab for ulcerative colitis: the new kid on the block?
Jitin Makker, Daniel W Hommes
Nature Reviews. Gastroenterology & Hepatology
|
February 18, 2016
Stem cells: HSCT for Crohn's disease: work in progress or a bridge too far?
Daniel W Hommes, Precious N Lacey
Gastroenterology
|
November 16, 2016
Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
Christopher J Hawkey, Daniel W Hommes
Therapeutic Advances in Gastroenterology
|
July 2, 2016
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls
Natalie E Duran, Daniel W Hommes
Current Treatment Options in Gastroenterology
|
August 12, 2006
Novel biological therapies for inflammatory bowel disease
Pieter C F Stokkers, Daniel W Hommes
Gastroenterology & Hepatology
|
August 21, 2013
Mucosal schwann cell hamartoma in ulcerative colitis: diagnosis and clinical relevance
Welmoed K van Deen, Daniel W Hommes
Nature Reviews. Gastroenterology & Hepatology
|
July 3, 2013
IBD: Antibodies to anti-TNF therapy--consequences for IBD management
Welmoed K van Deen, Daniel W Hommes
Current Gastroenterology Reports
|
March 15, 2006
Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
Luc J J Derijks, Daniel W Hommes
Page
of 13